We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Method Determines Optimal Number of Pathologists Needed for Correct Disease Diagnosis

By LabMedica International staff writers
Posted on 07 Feb 2022

A new method, named the Observers Needed for Evaluation of Subjective Tests (ONEST), has been developed to determine the optimal number of pathologists needed for a correct diagnosis. More...

The method developed by researchers at the Texas A&M University School of Public Health (College Station, TX, USA) could improve accuracy of disease diagnosis as pathology tests are mostly subjective, and even trained experts can disagree on results. The researchers developed a statistical framework to assess the performance of a diagnostic test with multiple observers. The proposed method includes an exploratory analysis, a statistical test of whether the observers’ agreement percentage will plateau to a non-zero value, and a statistical model to estimate the agreement percentage and the number of observers for reaching the plateau.

The method was applied in a non-small cell lung cancer example and a triple negative breast cancer example using reads of the immunohistochemical tests with SP142 and SP263 assays for expression of Programmed death-ligand 1 (PD-L1) to determine the number of observers needed for evaluation of the subjective tests. The proposed method can indicate whether adding more observers to a test causes the proportion of agreement to plateau. Cases where the curve does not plateau could indicate an unreliable test. In cases where the curve does flatten, the method indicates at least how many observers are needed to reach a stable and reliable estimation of their agreement.

Better understanding of how many observers are needed for optimal accuracy on a diagnostic test will help improve correct diagnosis, the right level of care and disease treatment. The researchers believe this method could be utilized by test creators and regulatory agencies to evaluate newly proposed subjective laboratory tests at different numbers of pathologists, which can ensure that the test will perform reliably in real-world settings.

Related Links:
Texas A&M University School of Public Health 


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Noul’s AI-based cervical cancer diagnostic solution, miLab CER (Photo courtesy of Noul)

AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America

Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.